Novo Holdings A/S’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-264,956
| Closed | -$34M | – | 29 |
|
|
2025
Q2 | $34M | Buy |
264,956
+36,152
| +16% | +$3.75M | 2.4% | 14 |
|
|
2025
Q1 | $20.3M | Buy |
228,804
+53,804
| +31% | +$5.25M | 1.54% | 19 |
|
|
2024
Q4 | $15.3M | Hold |
175,000
| – | – | 0.92% | 22 |
|
|
2024
Q3 | $16.2M | Hold |
175,000
| – | – | 0.8% | 28 |
|
|
2024
Q2 | $18.9M | Sell |
175,000
-183,626
| -51% | -$18.4M | 1.02% | 29 |
|
|
2024
Q1 | $34M | Sell |
358,626
-500
| -0.1% | -$42.9K | 2.35% | 15 |
|
|
2023
Q4 | $33.1M | Sell |
359,126
-165,874
| -32% | -$10.7M | 2.05% | 19 |
|
|
2023
Q3 | $26.4M | Buy |
525,000
+76,196
| +17% | +$4.07M | 1.95% | 20 |
|
|
2023
Q2 | $28.4M | Hold |
448,804
| – | – | 2.19% | 16 |
|
|
2023
Q1 | $20.2M | Buy |
448,804
+78,804
| +21% | +$3.55M | 1.33% | 24 |
|
|
2022
Q4 | $16.2M | Buy |
370,000
+53,326
| +17% | +$2.56M | 1.01% | 26 |
|
|
2022
Q3 | $20.9M | Hold |
316,674
| – | – | 0.99% | 20 |
|
|
2022
Q2 | $16M | Buy |
316,674
+89,148
| +39% | +$5.22M | 0.79% | 22 |
|
|
2022
Q1 | $14.5M | Buy |
227,526
+30,526
| +15% | +$2.19M | 0.77% | 25 |
|
|
2021
Q4 | $21.1M | Hold |
197,000
| – | – | 1% | 19 |
|
|
2021
Q3 | $20.3M | Hold |
197,000
| – | – | 1.05% | 21 |
|
|
2021
Q2 | $17.3M | Hold |
197,000
| – | – | 0.77% | 28 |
|
|
2021
Q1 | $19.2M | Hold |
197,000
| – | – | 0.79% | 25 |
|
|
2020
Q4 | $22.1M | Sell |
197,000
-37,979
| -16% | -$4M | 0.95% | 22 |
|
|
2020
Q3 | $21.8M | Sell |
234,979
-21,788
| -8% | -$1.68M | 1.08% | 18 |
|
|
2020
Q2 | $20M | Buy |
256,767
+22,500
| +10% | +$1.52M | 1.29% | 14 |
|
|
2020
Q1 | $13.7M | Buy |
234,267
+63,600
| +37% | +$4.09M | 0.91% | 12 |
|
|
2019
Q4 | $13.7M | Hold |
170,667
| – | – | 0.88% | 16 |
|
|
2019
Q3 | $12.5M | Buy |
170,667
+37,691
| +28% | +$3.26M | 2.15% | 12 |
|
|
2019
Q2 | $12.5M | Buy |
132,976
+65,409
| +97% | +$5.4M | 1.76% | 15 |
|
|
2019
Q1 | $5.41M | Buy |
+67,567
| New | +$4.99M | 0.8% | 18 |
|
Other funds holding BPMC
IA
HNB
Novo Holdings A/S's BPMC Position: Q3 2025 in Review
Novo Holdings A/S sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 264,956 shares — an estimated $34M sold.
Novo Holdings A/S first reported a position in BPMC in Q1 2019 and held it in 26 quarters. The position peaked at $34M in Q1 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Novo Holdings A/S reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Novo Holdings A/S sold 264,956 Blueprint Medicines shares in Q3 2025, an estimated $34M.
- Novo Holdings A/S first reported a position in Blueprint Medicines in Q1 2019 and held it in 26 quarters.
- Novo Holdings A/S's Blueprint Medicines position peaked at $34M in Q1 2024.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Novo Holdings A/S's 13F filing for Q3 2025, filed 14 Nov 2025.